These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

433 related items for PubMed ID: 21712309

  • 1. Lymph-node metastases in invasive lobular carcinoma are different from those in ductal carcinoma of the breast.
    Fernández B, Paish EC, Green AR, Lee AH, Macmillan RD, Ellis IO, Rakha EA.
    J Clin Pathol; 2011 Nov; 64(11):995-1000. PubMed ID: 21712309
    [Abstract] [Full Text] [Related]

  • 2. Is survival from infiltrating lobular carcinoma of the breast different from that of infiltrating ductal carcinoma?
    Jayasinghe UW, Bilous AM, Boyages J.
    Breast J; 2007 Nov; 13(5):479-85. PubMed ID: 17760669
    [Abstract] [Full Text] [Related]

  • 3. Clinical outcomes using accelerated partial breast irradiation in patients with invasive lobular carcinoma.
    Shah C, Wilkinson JB, Shaitelman S, Grills I, Wallace M, Mitchell C, Vicini F.
    Int J Radiat Oncol Biol Phys; 2011 Nov 15; 81(4):e547-51. PubMed ID: 21640491
    [Abstract] [Full Text] [Related]

  • 4. Does routine grading of invasive lobular cancer of the breast have the same prognostic significance as for ductal cancers?
    Sinha PS, Bendall S, Bates T.
    Eur J Surg Oncol; 2000 Dec 15; 26(8):733-7. PubMed ID: 11087636
    [Abstract] [Full Text] [Related]

  • 5. [Accuracy of conservative treatment for infiltrating lobular breast cancer: a retrospective study of 217 infiltrating lobular carcinomas and 2155 infiltrating ductal carcinomas].
    Paumier A, Sagan C, Campion L, Fiche M, Andrieux N, Dravet F, Pioud R, Classe JM.
    J Gynecol Obstet Biol Reprod (Paris); 2003 Oct 15; 32(6):529-34. PubMed ID: 14593298
    [Abstract] [Full Text] [Related]

  • 6. Lobular and non-lobular breast cancers differ regarding axillary lymph node metastasis: a cross-sectional study on 4,292 consecutive patients.
    Vandorpe T, Smeets A, Van Calster B, Van Hoorde K, Leunen K, Amant F, Moerman P, Deraedt K, Brouckaert O, Van Huffel S, Wildiers H, Christiaens MR, Neven P.
    Breast Cancer Res Treat; 2011 Jul 15; 128(2):429-35. PubMed ID: 21562708
    [Abstract] [Full Text] [Related]

  • 7. The incidence and significance of micrometastases in lymph nodes of patients with ductal carcinoma in situ and T1a carcinoma of the breast.
    Broekhuizen LN, Wijsman JH, Peterse JL, Rutgers EJ.
    Eur J Surg Oncol; 2006 Jun 15; 32(5):502-6. PubMed ID: 16569492
    [Abstract] [Full Text] [Related]

  • 8. Tumor characteristics and patient outcomes are similar between invasive lobular and mixed invasive ductal/lobular breast cancers but differ from pure invasive ductal breast cancers.
    Bharat A, Gao F, Margenthaler JA.
    Am J Surg; 2009 Oct 15; 198(4):516-9. PubMed ID: 19800459
    [Abstract] [Full Text] [Related]

  • 9. The Yale University experience of early-stage invasive lobular carcinoma (ILC) and invasive ductal carcinoma (IDC) treated with breast conservation treatment (BCT): analysis of clinical-pathologic features, long-term outcomes, and molecular expression of COX-2, Bcl-2, and p53 as a function of histology.
    Moran MS, Yang Q, Haffty BG.
    Breast J; 2009 Oct 15; 15(6):571-8. PubMed ID: 19995377
    [Abstract] [Full Text] [Related]

  • 10. Outcomes of breast-conservation therapy for invasive lobular carcinoma are equivalent to those for invasive ductal carcinoma.
    Vo TN, Meric-Bernstam F, Yi M, Buchholz TA, Ames FC, Kuerer HM, Bedrosian I, Hunt KK.
    Am J Surg; 2006 Oct 15; 192(4):552-5. PubMed ID: 16978974
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Lobular breast cancer: same survival and local control compared with ductal cancer, but should both be treated the same way? analysis of an institutional database over a 10-year period.
    Fortunato L, Mascaro A, Poccia I, Andrich R, Amini M, Costarelli L, Cortese G, Farina M, Vitelli C.
    Ann Surg Oncol; 2012 Apr 15; 19(4):1107-14. PubMed ID: 21913022
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Validation of axillary sentinel lymph node detection in the staging of early lobular invasive breast carcinoma: a prospective study.
    Classe JM, Loussouarn D, Campion L, Fiche M, Curtet C, Dravet F, Pioud R, Rousseau C, Resche I, Sagan C.
    Cancer; 2004 Mar 01; 100(5):935-41. PubMed ID: 14983488
    [Abstract] [Full Text] [Related]

  • 19. Sentinel Lymph Node Biopsy and Isolated Tumor Cells in Invasive Lobular Versus Ductal Breast Cancer.
    Truin W, Roumen RM, Siesling S, van der Heiden-van der Loo M, Lobbezoo DJ, Tjan-Heijnen VC, Voogd AC.
    Clin Breast Cancer; 2016 Aug 01; 16(4):e75-82. PubMed ID: 27116948
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.